Article
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.
AIDS (London, England) - 19 Jun 2009
Archer John, Braverman Michael S, Taillon Bruce E, Desany Brian, James Ian, Harrigan P Richard, Lewis Marilyn, Robertson David L
Abstract excerpt
OBJECTIVE: Identification of low-frequency variants is of clinical importance in the identification of preexisting drug resistance. Using 'ultra-deep' sequencing, we address the detection of potential resistance to the chemokine (C-C motif) receptor 5 (CCR5) antagonist, maraviroc, due to the pretreatment presence of low levels of chemokine (CXC motif) receptor 4 (CXCR4)-using virus. METHODS: We present a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
